STAT Plus: Key Senate committee advances its sweeping drug pricing bill — and keeps caps on price hikes
WASHINGTON — A key Senate committee on Thursday advanced a sweeping bill to lower drug prices after its members voted — narrowly — to retain its most controversial element: a cap on some drug price increases under Medicare.
The broader package passed by a 19-9 margin and earned unanimous support from Democrats. GOP lawmakers opposed the legislation by a 9-5 margin.
